EP Patent

EP1304130B1 — Inhalationstherapievorrichtung

Assigned to PARI GmbH Spezialisten fuer Effektive Inhalation · Expires 2004-06-23 · 22y expired

What this patent protects

Patent listed against amikacin-sulfate.

Drugs covered by this patent

amikacin-sulfate (AMIKACIN SULFATE)

Patent Metadata

Patent number: EP1304130B1
Jurisdiction: EP
Classification: —
Expires: 2004-06-23
Drug substance claim: No
Drug product claim: No
Assignee: PARI GmbH Spezialisten fuer Effektive Inhalation
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.